130 related articles for article (PubMed ID: 12921115)
1. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R
Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of recurrent subcutaneous abscesses using granulocyte and monocyte adsorptive apheresis.
Okamura K; Nikaido M; Saito T; Arai Y; Yoshioka C; Yagi M; Komoriya H; Takahashi N; Hozumi Y; Suzuki T
J Dermatol; 2024 Mar; ():. PubMed ID: 38507463
[No Abstract] [Full Text] [Related]
3. Correction to: A novel selective leukocyte depletion human whole blood model reveals the specific roles of monocytes and granulocytes in the cytokine response to Escherichia coli.
J Leukoc Biol; 2024 May; 115(6):1190. PubMed ID: 38620070
[No Abstract] [Full Text] [Related]
4. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
[TBL] [Abstract][Full Text] [Related]
5. Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes.
Yoshimura N; Tadami T; Kawaguchi T; Sako M; Yoshimoto H; Yamaka T; Takazoe M
J Gastroenterol; 2012 Jan; 47(1):49-55. PubMed ID: 21915624
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis.
Thanaraj S; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1297-306. PubMed ID: 21050231
[TBL] [Abstract][Full Text] [Related]
7. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
[TBL] [Abstract][Full Text] [Related]
8. Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis.
Tanaka T; Okanobu H; Kuga Y; Yoshifuku Y; Fujino H; Miwata T; Moriya T; Nishida T; Oya T
Gastroenterol Clin Biol; 2010 Dec; 34(12):687-95. PubMed ID: 20934287
[TBL] [Abstract][Full Text] [Related]
9. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
[TBL] [Abstract][Full Text] [Related]
11. Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG; Rutgeerts P; Sands BE; Hanauer S; Colombel JF; Sandborn WJ; Van Assche G; Axler J; Kim HJ; Danese S; Fox I; Milch C; Sankoh S; Wyant T; Xu J; Parikh A;
N Engl J Med; 2013 Aug; 369(8):699-710. PubMed ID: 23964932
[TBL] [Abstract][Full Text] [Related]
12. Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis Achieved Ulcer Healing for Pyoderma Gangrenosum.
Tanida S; Kubo R; Yoshii S; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
J Clin Med Res; 2023 Dec; 15(10-11):446-455. PubMed ID: 38189038
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Granulomonocytapheresis as a Non-pharmacologic Treatment Option for Inflammatory Bowel Disease: Efficacy Reports on a Wide Age Range and Disease Profile.
Tanaka T
Cureus; 2023 Nov; 15(11):e48913. PubMed ID: 38106709
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases - a case report and literature review.
Mastronardi M; Cavalcanti E; Labarile N; Armentano R; Gabriele F; Curlo M
Ther Adv Chronic Dis; 2023; 14():20406223231194190. PubMed ID: 37928629
[TBL] [Abstract][Full Text] [Related]
15. Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports.
Furuto Y; Sawada R; Namikawa A; Matsuhashi N; Shibuya Y
Cureus; 2023 Aug; 15(8):e43599. PubMed ID: 37719478
[TBL] [Abstract][Full Text] [Related]
16. Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor.
Tanida S; Ozeki K; Katano T; Tanaka M; Shimura T; Kubota E; Kataoka H; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
J Clin Med Res; 2023 Mar; 15(3):181-186. PubMed ID: 37035853
[TBL] [Abstract][Full Text] [Related]
17. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease.
Yasmin F; Najeeb H; Naeem U; Moeed A; Koritala T; Surani S
World J Clin Cases; 2022 Jul; 10(21):7195-7208. PubMed ID: 36158031
[TBL] [Abstract][Full Text] [Related]
18. Intracellular communication and immunothrombosis in sepsis.
Iba T; Levi M; Levy JH
J Thromb Haemost; 2022 Nov; 20(11):2475-2484. PubMed ID: 35979601
[TBL] [Abstract][Full Text] [Related]
19. For safe and adequate blood purification therapy in severe COVID-19 ‒ what we have learned so far.
Katagiri D
Glob Health Med; 2022 Apr; 4(2):94-100. PubMed ID: 35586758
[TBL] [Abstract][Full Text] [Related]
20. Induction of mucosal healing by intensive granulocyte/monocyte adsorptive apheresis (GMA) without use of corticosteroids in patients with ulcerative colitis: long-term remission maintenance after induction by GMA and efficacy of GMA re-treatment upon relapse.
Fukuchi T; Kawashima K; Koga H; Utsunomiya R; Sugiyama K; Shimazu K; Eguchi T; Ishihara S
J Clin Biochem Nutr; 2022 Mar; 70(2):197-204. PubMed ID: 35400813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
